Genesys BioLabs, a business unit of 20/20 Genesystems, Inc., is dedicated to offering the most accurate and well validated biomarker based tests to aide in the early detection of lung cancer. Our laboratory is CLIA certified and has state licensure from Maryland, Pennsylvania and Rhode Island. We are staffed by a team of Ph.D. and M.D. level scientists and a management group that collectively has more than 50 years of experience in the diagnostics industry. We also have a Medical Advisory Board made up of practicing physicians from diverse specialties including primary care, pulmonary, radiology and thoracic surgery.